Specialists for Myxopapillary ependymoma

13 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Ernest C. Borden, MD
Rare Disease / Clinical Research
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
PI×5
Jana Portnow, MD, MD
Rare Disease / Clinical Research
City of Hope Comprehensive Cancer Center
DUARTE, CA
PI×3
Shivaani Kummar, MD
Rare Disease / Clinical Research
NCI - Medical Oncology Branch
PORTLAND, OR
PI×6
Michael E. Rytting, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
EL PASO, TX
PI×3
Scot C. Remick, MD, MD
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
PI×10
Antonio Omuro, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
STANFORD, CA
PI×1
John Suh, MD
Rare Disease / Clinical Research
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
PI×1
Stephen Rapp, PhD
Rare Disease / Clinical Research
Wake Forest University Health Sciences
PI×1
Sarah J. Nelson, PhD
Rare Disease / Clinical Research
University of California, San Francisco
PI×1
Robert J. Morgan, MD
Rare Disease / Clinical Research
City of Hope Comprehensive Cancer Center
PI×2
Edward G. Shaw, MD
Rare Disease / Clinical Research
Wake Forest University Health Sciences
PI×4
Stephen Forman, MD
Rare Disease / Clinical Research
City of Hope Comprehensive Cancer Center
PI×1
Robert T. Blackwood, PA-S
Rare Disease / Clinical Research
Wake Forest University Health Sciences
PI×1

More about Myxopapillary ependymoma